J&J vaccination programme on track to restart this week
The country’s vaccination programme (Sisonke 3B implementation study) may restart in a matter of days, reported Business Day (19 April 2021). The resumption depends on the approval of Johnson & Johnson (J&J) updated protocol by the SA Health Products Regulatory Authority (SAHPRA) and a group of university research ethics committees.
The programme was suspended last week as scientists evaluated the possible link between the vaccine and a rare type of blood clotting in the brain. So far, 292 623 healthcare workers have had the vaccine, with just over 200 000 outstanding under the first phase.
Under the current plan, another 500 000-700 000 units of commercial J&J stock will arrive in SA from April 24, with the first batches of Pfizer stock arriving in early May.